Trial intelligence / Profile preview

Prevena vs Prineo vs Traditional Dressing in Abdominal Wall Reconstruction

NCT04906408Recruiting

Sponsor
The Ohio State University
Start
Sep 2021
Primary completion
May 2028
Countries
1
01

Overview

Randomised, open-label trial in ventral hernia and Abdominal wall neoplasm (3 arms), sponsored by The Ohio State University. Primary endpoints: Rate of Infection at 6 weeks, Rate of Seroma at 6 weeks and 2 more. Started Sep 2021; status: recruiting.

02

Conditions

ventral herniaAbdominal wall neoplasm

Beyond the preview

Go deeper on NCT04906408.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04906408.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call